Cas:1137-77-5 4′-Methoxy-4-biphenylamine manufacturer & supplier

Chemical Name:4′-Methoxy-4-biphenylamine

CAS.NO:1137-77-5

Synonyms:MFCD00047858;4-(4-methoxyphenyl)aniline;[1,1′-Biphenyl]-4-amine, 4′-methoxy-;4′-methoxybiphenyl-4-amine;4′-Methoxy-4-biphenylamine

Molecular Formula:C₁₃H₁₃NO

Molecular Weight:199.248

HS Code:2922299090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:347.1±25.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.598

PSA:35.25000

Exact Mass:199.099716

LogP:2.59

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like MFCD00047858 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4′-Methoxy-4-biphenylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,[1,1′-Biphenyl]-4-amine, 4′-methoxy- Use and application,4′-methoxybiphenyl-4-amine technical grade,usp/ep/jp grade.

Related News: Lilly has denied retaliating against any employees, and no lawsuit has been filed on behalf of Mula. 4′-Methoxy-4-biphenylamine manufacturer Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country. 4′-Methoxy-4-biphenylamine supplier Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control. 4′-Methoxy-4-biphenylamine vendor Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control. 4′-Methoxy-4-biphenylamine factory At the same time, because the profits of a single variety of characteristic APIs do not have long-term growth, companies need more product reserves.